Nutritional combinatorial impact on the gut microbiota and plasma short-chain fatty acids levels in the prevention of mammary cancer in Her2/neu estrogen receptor-negative transgenic mice
M. Sharma, I. Arora, M. L. Stoll, Y. LiiD, C. D. Morrow, S. Barnes, T. F. Berryhill, S. Li, T. O. Tollefsbol
Abstract
Breast cancer is the second leading cause of cancer-related mortality in women. Various nutritional compounds possess anti-carcinogenic properties which may be mediated through their effects on the gut microbiota and its production of short-chain fatty acids (SCFAs) for the prevention of breast cancer. We evaluated the impact of broccoli sprouts (BSp), green tea polyphenols (GTPs) and their combination on the gut microbiota and SCFAs metabolism from the microbiota in Her2/neu transgenic mice that spontaneously develop estrogen receptor-negative [ER (-)] mammary tumors. The mice were grouped based on the dietary treatment: control, BSp, GTPs or their combination from beginning in early life (BE) or life-long from conception (LC). We found that the combination group showed the strongest inhibiting effect on tumor growth volume and a significant increase in tumor latency. BSp treatment was integrally more efficacious than the GTPs group when compared to the control group. There was similar clustering of microbiota of BSp-fed mice with combination-fed mice, and GTPs-fed mice with control-fed mice at pre-tumor and post-tumor in both BE and LC groups. The mice on all dietary treatment groups incurred a significant increase of Adlercreutzia genus and S24-7 family in the both BE and LC groups. We found no change in SCFAs levels in the plasma of BSp-fed, GTPs-fed and combination-fed mice of the BE group. Marked changes were observed in the mice of the LC group consisting of significant increases in propionate and isobutyrate in GTPs-fed and combination-fed mice. These studies indicate that nutrients such as BSp and GTPs differentially affect the gut microbial composition in both the BE and LC groups and the key metabolites (SCFAs) levels in the LC group. The findings also suggest that temporal factors related to different time windows of consumption during the life-span can have a promising influence on the gut microbial composition, SCFAs profiles and ER (-) breast cancer prevention.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dietary sulfate-driven and gut dysbiosis-triggered breast cancer-related gene upregulation
CHEN YanPingf, LIAO Tao, … ZHEN QingPing·bioRxiv·Oct 10, 2018
- Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumour growth via a mast cell-dependent pathway
B. M. Kirkup, A. M. McKee, … S. D. Robinson·bioRxiv·Mar 7, 2020
- Perturbation of the gut microbiota by antibiotics results in accelerated breast tumour growth and metabolic dysregulation
B. Kirkup, A. McKee, … S. D. Robinson·bioRxiv·Feb 19, 2019
- Construction of Model Animals to Explore Intestinal Microbiome for Detection of Breast Cancer
- Loss of Mast cells and histaminergic signaling link diet to platelet-mediated NETosis and mammary cancer recurrence
Claire P. Schane, Adam T. Nelczyk, … Erik Russell Nelson·bioRxiv·Apr 15, 2026
- Estrogen Signaling During Abrupt Involution Leads to Long-Term Metabolic Dysfunction Similar to Estrogen Receptor Negative Breast Cancer
Kate Ormiston, Neelam Shinde, … Daniel G. Stover·bioRxiv·Oct 9, 2025